A. SLE requires multidisciplinary, individualised management with patient education and shared decision- making, taking into consideration the costs to patient and society  B. SLE disease activity should be assessed at each clinic visit (the frequency depending on physician’s discretion), with evaluation of organ damage (at least annually), using validated instruments.   C. Non- pharmacological interventions, including…

Non-Renal Systemic Lupus Erythematosus Figure 1 Treatment of non- renal systemic lupus erythematosus. Fanouriakis A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis Epub doi:10.1136/ard-2023 224762 Top- to bottom sequence does not imply order of preference (eg, MTX, AZA and MMF are equal options for second- line therapy in mild…